¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"ALPHA GALACTOSIDASE ENZYME"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
enzyme
È¿¼Ò
enzyme activity
È¿¼ÒȰ¼º, È¿¼ÒȰ¼ºµµ
enzyme assay
È¿¼ÒÃøÁ¤
enzyme immunoassay
È¿¼Ò¸é¿ªºÐ¼®(¹ý)
enzyme inhibition
È¿¼Ò¾ïÁ¦
enzyme inhibitor
È¿¼Ò¾ïÁ¦Á¦
enzyme labeled antibody
È¿¼ÒÇ¥ÁöÇ×ü
enzyme labeling
È¿¼ÒÇ¥Áö
enzyme modulator mediated immunoassay
È¿¼ÒÁ¶Àý¸Å°³¸é¿ªºÐ¼®(¹ý)
enzyme precursor
È¿¼ÒÀü±¸¹°Áú
enzyme-antibody conjugate
È¿¼ÒÇ×üÁ¢ÇÕü
enzyme-antienzyme reaction
È¿¼ÒÇ×È¿¼Ò¹ÝÀÀ
enzyme-linked immunoelectrotransfer blot
È¿¼Ò°áÇո鿪ÀÌÀû¹ý, È¿¼Ò¿¬°ü¸é¿ªÀü±âÀü´Þ¹ý
enzyme-linked immunosorbent assay
È¿¼Ò°áÇո鿪ÈíÂøÃøÁ¤(¹ý)
fibrinolytic enzyme
¼¶À¯¼Ò¿ëÇØÈ¿¼Ò, ÇǺ기¿ëÇØÈ¿¼Ò
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
degumming enzyme
ÇØ±³È¿¼Ò
diastatic enzyme
´çÈÈ¿¼Ò
digestive enzyme
¼ÒÈÈ¿¼Ò
enzyme
È¿¼Ò
enzyme immunoassay
È¿¼Ò¸é¿ªºÐ¼®(¹ý)
enzyme inhibition
È¿¼Ò¾ïÁ¦
enzyme inhibitor
È¿¼Ò¾ïÁ¦Á¦
enzyme labeling
È¿¼ÒÇ¥Áö
enzyme precursor
È¿¼ÒÀü±¸Ã¼
enzyme modulator mediated immunoassay
È¿¼ÒÁ¶Àý¸Å°³¸é¿ªºÐ¼®(¹ý)
enzyme trace substance theory
È¿¼ÒÈçÀû¹°¼³
enzyme-antienzyme reaction
È¿¼ÒÇ×È¿¼Ò¹ÝÀÀ
extracellular enzyme
¼¼Æ÷¿ÜÈ¿¼Ò, ±Õü¹ÛÈ¿¼Ò
fibrinolytic enzyme
¼¶À¯¼Ò¿ëÇØÈ¿¼Ò
glycolytic enzyme
ÇØ´çÈ¿¼Ò
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
regulatory enzyme
Á¶ÀýÈ¿¼Ò(¡ý£áÈ).
17-alpha-hydroxycorticosteroid
17-¾ËÆÄ-È÷µå·Ï½ÃÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å
17-alpha-hydroxyprogesterone
17-¾ËÆÄ-È÷µå·Ï½ÃÇÁ·Î°Ô½ºÅ×·Ð
alpha behavior
¾ËÆÄÇàÀ§
alpha blocking
¾ËÆÄÂ÷´Ü
alpha cell
¾ËÆÄ¼¼Æ÷
alpha cell
¾ËÆÄ¼¼Æ÷(¡á¬øà)
alpha cell glucagon cell
¾ËÆÄ¼¼Æ÷ ±Û·çÄ«°ï¼¼Æ÷
alpha cell tumor
¾ËÆÄ ¼¼Æ÷Á¾(¡á¬øàðþ)
alpha chain disease
¾ËÆÄ¼âº´(¡áðÜ»).
alpha chain disease
¾ËÆÄ¼âÁúȯ
alpha cradle
¾ËÆÄ¹Þħ´ë
alpha decay
¾ËÆÄºØ±«
alpha emitter
¾ËÆÄ¹æ»çü, ¾ËÆÄ¹æÃâü
alpha fetoprotein =AFP
¾ËÆÄžƴܹé(¡÷Ãä®Ó±ÛÜ).
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
alpha rhythm
¾ËÆÄ¸®µë ³úÆÄ(Òà÷î)ÀÇ .
alpha thalassemia
¾ËÆÄÅ»¶ó¼¼¹Ì¾Æ.
alpha thalassemia
¾ËÆÄÁöÁßÇØºóÇ÷
alpha thalassemia
¾ËÆÄÅ»¶ó¼¼¹Ì¾Æ.
alpha toxin
¾ËÆÄ µ¶¼Ò (¡Ô¸áÈ)
alpha wave
¾ËÆÄÆÄ ³úÆÄ(Òà÷î)ÀÇ .
alpha-1-antittrypsin deficiensy
¾ËÆÄ-1-¾ÈƼƮ¸³½Å °áÇÌÁõ(¡ÌÀù¹ñø)
alpha-2-macroglobulin
¾ËÆÄ-2-¸¶Å©·Î±Û·ÎºÒ¸°
alpha-adrenal receptor antagonist
¾ËÆÄ ¾Æµå·¹³¯¸°¼ö¿ëüÂ÷´ÜÁ¦
alpha-adrenergic agonist
¾ËÆÄ¾Æµå·¹³¯¸°ÃËÁøÁ¦
alpha-adrenergic antagonist
¾ËÆÄ¾Æµå·¹³¯¸°±æÇ×Á¦
alpha-adrenergic receptor
¾ËÆÄ-¾Æµå·¹³¯¸°¼ö¿ëü.
alpha-adrenergic receptor
¾ËÆÄ¾Æµå·¹³¯¸°¼ö¿ëü
alpha-amino acid nitrogen
¾ËÆÄ-¾Æ¹Ì³ë»êÁú¼Ò
alpha-chain disease
¾ËÆÄ¼â Áúȯ(¡áð òðü´)
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½